Antonio Braghetti

Renal Artery Assessment with Nonenhanced Steady-State Free Precession versus Contrast-enhanced MR Angiography

Rolf Wyttenbach, Antonio Braghetti, Michael Wyss et al. · Radiology · 2007 · 93 citations

Clinical and pharmacological phase I evaluation of Exherin™ (ADH-1), a selective anti-N-cadherin peptide in patients with N-cadherin-expressing solid tumours

Antonella Perotti, Cristiana Sessa, Andrea Mancuso et al. · Annals of Oncology · 2009 · 72 citations · Full text

N-cadherin-expressing Solid Tumours, Pharmacological Phase, Medicine +9

Prospective Blinded Evaluation of Gd-DOTA– versus Gd-BOPTA–enhanced Peripheral MR Angiography, as Compared with Digital Subtraction Angiography

Rolf Wyttenbach, Sara Gianella, Mario Alerci et al. · Radiology · 2003 · 70 citations

Phase I Safety, Pharmacokinetic and Pharmacodynamic Evaluation of the Vascular Disrupting Agent Ombrabulin (AVE8062) in Patients with Advanced Solid Tumors

Cristiana Sessa, Patricia LoRusso, Anthony W. Tolcher et al. · Clinical Cancer Research · 2013 · 46 citations

A simple method for low-contrast detectability, image quality and dose optimisation with CT iterative reconstruction algorithms and model observers

Luca Bellesi, Rolf Wyttenbach, Diego Gaudino et al. · European Radiology Experimental · 2017 · 15 citations · Full text